Cross-sectional analysis identifies functional vulnerability zone using volumetric data in glaucoma patients, suggesting clinical applications.
ABSTRACT Purpose To use volumetric analysis applied to total deviation perimetric data to characterise the presence of residual sensitivity measurable using the 10-2 in lieu of the 24-2 test grid in glaucoma (the functional vulnerability zone, FVZ) and develop a prototype end-user application for clinical guidance. Design Cross-sectional study Subjects 626 pairs of Humphrey Field Analyzer 10-2 SITA-Fast and 24-2 SITA-Faster test results of 160 subjects. Methods Total deviation (TD) values located within 10o from fixation (10-2, 68 locations; 24-2, 12 locations) were extracted. Volumetric analysis was performed to calculate the difference in TD "volume" (10-2 – 24-2) for each pair of results. Then, 24-2 test locations were interpolated across the central 10o to obtain "equivalent" 10-2 test locations used to calculate number of test locations gained (10-2 – 24-2). A positive TD volume difference and positive gain represented the presence of an FVZ. Linear regression and principal components analysis (PCA) were used to identify 24-2 test features that may predict the presence of an FVZ. Main outcome measure Volumetric differences in visual field total deviation as a surrogate for a functional vulnerability zone. Results VF global indices and the number of central 24-2 defects predicted TD volume difference (p<0.0001), with 24-2 mean deviation (MD) showing the highest R² (0.32). All parameters had low R² values when predicting gain. A simplified model comprising 24-2 MD and number of central 24-2 TD probability (TDP) defects (p<0.01) provided a method for clinically identifying the likelihood of an FVZ. PCA revealed two principal components (24-2 global indices and pointwise probability scores) that accounted for 79.7% of the variance, with PC1 accounting for 69.3% and comprising 24-2 mean deviation and number of central 24-2 total deviation probability scores at p < 2%. Conclusions The FVZ offers a data-driven approach to identifying residual dynamic range using the 10-2 test grid. A prototype model for predicting the likelihood of 10-2 utility in progression analysis is proposed.
No takes yet. Share an insight, caveat, or question.
Phu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: